Catapult Therapeutics
Phase 1About us Catapult Therapeutics is a clinical-stage biopharmaceutical company developing CAP-100 – an anti-CCR7 antibody with a unique mechanism of ...
Founded
2015
Focus
AntibodiesBiologics
About
About us Catapult Therapeutics is a clinical-stage biopharmaceutical company developing CAP-100 – an anti-CCR7 antibody with a unique mechanism of ...
Funding History
4Total raised: $44.5M
Series A$16MYsios CapitalMar 15, 2023
Series A$20MForbionNov 15, 2022
Seed$3.5MBioGeneration VenturesJun 15, 2021
Seed$5MUndisclosedMar 15, 2021
Company Info
TypePrivate
Founded2015
LocationLeiden, Netherlands
StagePhase 1
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile